Read irishman #4758 reply. Lympro might have otherwise died had it not been for the astute AMBS team to recognize a great value and acquire it. That's why those companies that now have a renewed interest had not seen it for awhile. Don't worry about Lympro...AMBS is just getting the science and data in order. Soon we will all be pleasantly rewarded for being long in this stock.